Volume 13, Number 2—February 2007
Dispatch
Characteristics of Staphylococcus aureus Infections, Chicago Pediatric Hospital
Preeti Jaggi*, Suzanne M. Paule†, Lance R. Peterson†, and Tina Q. Tan*
Table 2
Susceptibility data for CA-MRSA isolates from children*
| Susceptibility to antimicrobial agent† | CA-MRSA isolates causing invasive disease, n (%) | CA-MRSA isolates causing local skin/soft tissue infections, n (%) | p value |
|---|---|---|---|
| Resistant to erythromycin | 16/18 (88.9) | 11/18 (61) | NS |
| Apparently susceptible to clindamycin | 18/18 (100) | 18/18 (100) | NS |
| Inducible clindamycin resistance | 3/16 (19) | 0/10 (0) | NS |
| Resistant to ciprofloxacin | 2/18 (11) | 1/18 (6) | NS |
| Resistant to levofloxacin | 1/18 (6) | 1/18 (6) | NS |
| Resistant to tetracycline | 1/18 (5) | 2/18 (11) | NS |
*CA-MRSA, community-associated methicillin-resistant Staphylococcus aureus; NS, not significant.
†In addition to the antimicrobial agents listed, all isolates were susceptible to vancomycin, linezolid, and rifampin.
